European Living with Rheumatoid Arthritis Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Living with Rheumatoid Arthritis - Europe - 2016" report to their offering.

Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with rheumatoid arthritis?

Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.

RA is a progressive and debilitating disease which affects around 3m people in Europe. The RA market is about to undergo significant changes in the next few years as newer entrants with novel modes of action compete with established brands, and biosimilars become accepted for use as cheaper alternatives to the branded biologics.

This new study follows our previous wave of research conducted in 2011, across the main 5 EU markets.

This report gives you an in-depth understanding of:

- Life with rheumatoid arthritis from the patient perspective

- Attitudes to rheumatoid arthritis and the impact it has on patients' lives

- Attitudes to interaction with physicians/nurses/therapists

- Attitudes towards treatments received, including differences between biologics and non-biologics

- Treatment sequencing

- Awareness of and attitudes towards biosimilars

- Patient segments

- Suggested improvements and unmet needs in treatments

The full Powerpoint report includes a patient segmentation analysis.

Living with RA Report

- Quantitative online study

- Biologics patients: 35 minute online survey

- Non-biologics patients: 30 minute online survey

Countries

- France - Total RA Patients 100

- Germany - Total RA Patients 100

- Italy - Total RA Patients 100

- Spain - Total RA Patients 100

- UK - Total RA Patients 100

Sample considerations

- Patients diagnosed with Rheumatoid Arthritis and receiving at least one pharmaceutical treatment

- Mix of biologics and non-biologics patients, to reflect treatment patterns (-40% on biologics)

- Representative spread of demographics per market

- Male 34%, Female 66%

- 18-39 years 18%, 40-60 years 55%, 61+ years 27%

For more information visit http://www.researchandmarkets.com/research/mnskfj/living_with

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Musculoskeletal Disorders Drugs